Product category:
Contract research
News Release from: ClinPhone
Edited by the Laboratorytalk Editorial
Team on 30 January 2003
Appointment of financial director
Company plans stock market flotation but says the timing of this remains uncertain due to market conditions
ClinPhone has appointed the Steven Kent as its new financial director Kent, from Cambridge, will be responsible for the overall financial strategy of the company as it continues to grow and develop its market share in the global pharmaceutical and biotechnology industries
This article was originally published on Laboratorytalk on 20 May 2003 at 8.00am (UK)
Related stories
The 'perfect' patient diary solution
Interactive voice response firm thinks clinical trials industry is not yet fully aware that interactive voice response is the most effective method of gathering patient diary information
IVR becomes 'favoured' patient diary technology
Interactive voice response increasingly seen as preferable to hand held devices for patient data collection services, says promoter of the system
Flotation is a long-term goal, but Kent believes his immediate role is to ensure the company makes all of the right moves to maximise its attractiveness to investors.
"The company would like to go for an IPO (Initial Public Offering) on the stock market, but the timing of this is not clear cut and we all have to work towards the right moment," he explained.
"The share price of any business immediately after the initial public offering is about 80% to do with the market conditions and 20% to do with the company.
Further reading
Partnership to accelerate patient recruitment
Companies join forces to transform the methods used by biopharmaceutical companies to contact, recruit and retain clinical trial patients
Growth for clinical trials management software
Comprehensive 21 CFR 11 compliant database designed for day-to-day tracking and reporting of regulatory and clinical information
Clearly in the current climate, it's not an option - but we are examining the situation all of the time and when the trading conditions become more favourable, we aim to be ready." ClinPhone provides electronic clinical trial management solutions, including its market-leading Interactive Voice Response (IVR) services and unique web-based solutions designed to increase efficiency in the drug development process and accelerate the process of bringing new drugs to market.
It employs more than 325 people worldwide and has offices in Chicago, Princeton, and Palo Alto in the USA in addition to European facilities in Brussels and Heidelberg supporting the global headquarters in Nottingham.
Kent (40) qualified as an accountant with Rhone-Poulenc, working with the company for four and a half years.
After a short time at Dunhill he joined Sherwood Computers in 1988 and became financial controller of the company.
In May 1991 he joined a subsidiary of ICL as finance director and led a management buyout of the subsidiary, Workplace Technologies in 1995.
The company grew rapidly and was floated in 1997.
He then steered the company through an acquisition of computer network rival Lanbase, and the acquisition of the combined company by NTL in 1999.
Looking ahead to the future, he concluded: "Coming from an IT and accountancy background, it's exciting to see where ClinPhone is right now.
I believe it has enormous potential.
"It has successfully solved issues in the pharmaceutical industry using solutions from the IT industry and is consequently a world leader already. Request free introductory details about products from ClinPhone ...
There is much more to come and I am very much looking forward to being a key player in driving ClinPhone forward successfully towards its medium and long-term objectives.".
• ClinPhone: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
